MAGGIE CALLAN: Open Payments
NPI 1841931425 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 75 payments from 14 companies in 2025. Trend: 2023 $719 · 2024 $1,220 · 2025 $1,355
Food & beverage: $1,265Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $333 |
| ABBVIE INC. | 17 | $256 |
| UCB, Inc. | 13 | $143 |
| Lilly USA, LLC | 6 | $139 |
| Incyte Corporation | 1 | $100 |
| GENZYME CORPORATION | 1 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $43 |
Products named: TREMFYA, Bimzelx, RINVOQ, EBGLYSS, SKYRIZI, Opzelura, DUPIXENT, COSENTYX.
Industry payments across WA — which companies pay providers there.
